Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon)

ClinicalTrials.gov ID: NCT05651711

Public ClinicalTrials.gov record NCT05651711. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 11:29 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, 24-week, Placebo-controlled, Double-blind Study to Assess the Efficacy, Safety and Tolerability of Rocatinlimab (AMG 451) Monotherapy in Adult Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The co-primary objectives of the study are to: * Evaluate the efficacy of rocatinlimab compared with placebo at Week 24, assessed using Validated Investigator's Global Assessment for Atopic Dermatitis (vIGA-AD). * Evaluate the efficacy of rocatinlimab compared with placebo at Week 24, assessed using Eczema Area and Severity Index (EASI).

Study identification

NCT ID
NCT05651711
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Amgen
Industry
Enrollment
726 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 100 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 14, 2022 (Actual)
Primary completion
Jun 5, 2024 (Actual)
Completion
Aug 27, 2024 (Actual)
Last update posted
Jun 26, 2026

2022 – 2024

United States locations

U.S. sites
69
U.S. states
26
U.S. cities
61
Facility City State ZIP Site status
Research Solutions of Arizona, PC Litchfield Park Arizona 85340 —
Center for Dermatology and Plastic Surgery Scottsdale Arizona 85260 —
Clinical Trials Institute of Northwest Arkansas Fayetteville Arkansas 72703 —
Burke Pharmaceutical Research Hot Springs Arkansas 71913 —
Velocity Clinical Research Chula Vista Chula Vista California 91911 —
West Coast Research LLC Dublin California 94568 —
California Dermatology and Clinical Research Institute Encinitas California 92024 —
Center for Dermatology Clinical Research Inc Fremont California 94538 —
Velocity Clinical Research - San Diego La Mesa California 91942 —
Velocity Clinical Research - North Hollywood North Hollywood California 91606 —
Cura Clinical Research Palmdale California 93551 —
University of California at San Francisco, Dermatology Clinic at Mount Zion San Francisco California 94115 —
Clinical Science Institute Santa Monica California 90404 —
Clarity Dermatology Castle Rock Colorado 80109 —
Velocity Clinical Research - Denver Denver Colorado 80209 —
Foxhall Research Center Washington D.C. District of Columbia 20016 —
Renaissance Research and Medical Group Cape Coral Florida 33991 —
Driven Research LLC Coral Gables Florida 33134 —
Saint Jude Clinical Research Doral Florida 33172 —
Direct Helpers Research Center Hialeah Florida 33012 —
Glick Skin Institute Margate Florida 33063 —
Miami Dade Medical Research Institute, LLC Miami Florida 33176 —
Innovation Medical Research Center Inc Palmetto Bay Florida 33157 —
University of South Florida Health Morsani Center for Advanced Healthcare Tampa Florida 33612 —
Advanced Medical Research PC Sandy Springs Georgia 30328 —
Sneeze, Wheeze, and Itch Associates, LLC Normal Illinois 61761 —
The South Bend Clinic LLP South Bend Indiana 46617 —
Options Research Group LLC West Lafayette Indiana 47906 —
Dermatology and Skin Cancer Center of Overland Park Overland Park Kansas 66223 —
DS Research Louisville Kentucky 40241 —
Kentucky Advanced Medical Research LLC Murray Kentucky 42071 —
MetroBoston Clinical Partners Brighton Massachusetts 02135 —
Wendy Sadoff MD Dermatology PC Farmington Hills Michigan 48334 —
Revival Research Institute LLC Troy Michigan 48084 —
Somerset Skin Centre Troy Michigan 48084 —
Advanced Dermatology of the Midlands Omaha Nebraska 68144 —
James Del Rosso Dermatology Research Las Vegas Nevada 89117 —
Skin Cancer and Dermatology Institute Reno Nevada 89509 —
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03766 —
Weiss Medical Riverdale New Jersey 07457 —
Corning Center For Clinical Research Horseheads New York 14845 —
Forest Hills Dermatology Group Kew Gardens New York 11415 —
Crystal Run Healthcare Monroe New York 10950 —
Ace Clinical Trials New York New York 10022 —
Icahn School of Medicine at Mount Sinai New York New York 10029 —
OptiSkin Medical New York New York 10128 —
Montefiore Medical Center The Bronx New York 10467 —
Duke South Durham Durham North Carolina 27713 —
University of Cincinnati Cincinnati Ohio 45219 —
Bernstein Clinical Research Center LLC Cincinnati Ohio 45236 —
The Ohio State University Dermatology East Gahanna Ohio 43230 —
Velocity Clinical Research - Grants Pass Grants Pass Oregon 97527 —
Oregon Medical Research Center Portland Oregon 97223 —
Asthma and Allergy Physicians of Rhode Island Clinical Research Institute Warwick Rhode Island 02886 —
Bellaire Dermatology Associates Bellaire Texas 77401 —
US Dermatology Partners Cedar Park Cedar Park Texas 78613 —
Alina Clinical Trials, LLC Dallas Texas 75225 —
Zenos Clinical Research, LLC Dallas Texas 75230 —
The University of Texas Health Science Center at Houston Houston Texas 77030 —
MedCare Pharma - Houston Houston Texas 77037 —
FMCScience LLC Lampasas Texas 76550 —
Epic Clinical Research Incorporated Lewisville Texas 75057 —
Sienna Dermatology Research Missouri City Texas 77459 —
Texas Dermatology and Laser Specialists San Antonio Texas 78218 —
Andante Research San Antonio Texas 78229 —
Dermatology Clinical Research Center of San Antonio San Antonio Texas 78229 —
University of Utah MidValley Dermatology Murray Utah 84107 —
Eastern Virginia Medical School Norfolk Virginia 23507 —
MultiCare Institute for Research and Innovation Spokane Washington 99202 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 128 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05651711, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 26, 2026 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05651711 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →